GS71.DE vs. GILD
Compare and contrast key facts about GSK plc (GS71.DE) and Gilead Sciences, Inc. (GILD).
Performance
GS71.DE vs. GILD - Performance Comparison
Loading graphics...
GS71.DE vs. GILD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GS71.DE GSK plc | 15.88% | 35.15% | 2.16% | 6.35% | -12.22% | 39.12% | -22.83% | 37.08% | 19.67% | -12.30% |
GILD Gilead Sciences, Inc. | 16.73% | 20.38% | 26.52% | -4.93% | 31.29% | 39.68% | -14.39% | 10.32% | -5.69% | -9.70% |
Different Trading Currencies
GS71.DE is traded in EUR, while GILD is traded in USD. To make them comparable, the GILD values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, GS71.DE achieves a 15.88% return, which is significantly lower than GILD's 16.73% return. Over the past 10 years, GS71.DE has outperformed GILD with an annualized return of 9.70%, while GILD has yielded a comparatively lower 7.65% annualized return.
GS71.DE
- 1D
- 2.03%
- 1M
- -3.09%
- YTD
- 15.88%
- 6M
- 27.38%
- 1Y
- 42.16%
- 3Y*
- 19.50%
- 5Y*
- 15.21%
- 10Y*
- 9.70%
GILD
- 1D
- 0.56%
- 1M
- -4.96%
- YTD
- 16.73%
- 6M
- 29.60%
- 1Y
- 20.77%
- 3Y*
- 20.61%
- 5Y*
- 20.97%
- 10Y*
- 7.65%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GS71.DE vs. GILD — Risk / Return Rank
GS71.DE
GILD
GS71.DE vs. GILD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GSK plc (GS71.DE) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GS71.DE | GILD | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.55 | 0.70 | +0.85 |
Sortino ratioReturn per unit of downside risk | 2.18 | 1.23 | +0.95 |
Omega ratioGain probability vs. loss probability | 1.29 | 1.14 | +0.15 |
Calmar ratioReturn relative to maximum drawdown | 2.99 | 1.21 | +1.78 |
Martin ratioReturn relative to average drawdown | 7.33 | 3.11 | +4.23 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GS71.DE | GILD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.55 | 0.70 | +0.85 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.66 | 0.87 | -0.20 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.43 | 0.29 | +0.14 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.15 | 0.48 | -0.33 |
Correlation
The correlation between GS71.DE and GILD is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
GS71.DE vs. GILD - Dividend Comparison
GS71.DE's dividend yield for the trailing twelve months is around 3.63%, more than GILD's 2.27% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GS71.DE GSK plc | 3.63% | 4.10% | 5.04% | 4.40% | 6.27% | 6.75% | 8.46% | 6.08% | 7.69% | 8.73% | 9.48% | 8.41% |
GILD Gilead Sciences, Inc. | 2.27% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
Drawdowns
GS71.DE vs. GILD - Drawdown Comparison
The maximum GS71.DE drawdown since its inception was -65.83%, which is greater than GILD's maximum drawdown of -50.19%. Use the drawdown chart below to compare losses from any high point for GS71.DE and GILD.
Loading graphics...
Drawdown Indicators
| GS71.DE | GILD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.83% | -70.83% | +5.00% |
Max Drawdown (1Y)Largest decline over 1 year | -15.53% | -13.77% | -1.76% |
Max Drawdown (5Y)Largest decline over 5 years | -29.63% | -26.59% | -3.04% |
Max Drawdown (10Y)Largest decline over 10 years | -30.40% | -36.01% | +5.61% |
Current DrawdownCurrent decline from peak | -6.15% | -9.44% | +3.29% |
Average DrawdownAverage peak-to-trough decline | -25.97% | -22.20% | -3.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.33% | 5.08% | +1.25% |
Volatility
GS71.DE vs. GILD - Volatility Comparison
GSK plc (GS71.DE) has a higher volatility of 6.30% compared to Gilead Sciences, Inc. (GILD) at 6.00%. This indicates that GS71.DE's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| GS71.DE | GILD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.30% | 6.00% | +0.30% |
Volatility (6M)Calculated over the trailing 6-month period | 17.42% | 18.90% | -1.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.16% | 29.84% | -2.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.83% | 24.35% | -1.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.35% | 26.31% | -3.96% |
Financials
GS71.DE vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between GSK plc and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities